The Delhi High Court on Tuesday issued notice to the Centre, through the National Pharmaceuticals Pricing Authority (NPPA) and Department of Pharmaceuticals, on a Public Interest LitIgation (PIL) demanding to enforce a robust system of requirement of supporting clinical study and data prior to grant of approval for use of cardiac stents or coronary stents in India.
The Delhi High Court on Tuesday issued notice on a Public Interest Litigation (PIL) seeking direction to the Ministry of Health and Family Welfare to evolve and enforce a robust system of requirements of supporting clinical study and scrutiny of the same, prior to the grant of approval for marketing or sale and use in India, of cardiac stents or coronary stents by manufacturers and importers.
The Delhi High Court on Tuesday issued notice to the Centre, through the National Pharmaceuticals Pricing Authority (NPPA) and Department of Pharmaceuticals, on a Public Interest LitIgation (PIL) demanding to enforce a robust system of .
Get latest articles and stories on India at LatestLY. The plea stated that at present cardiac stents or coronary stents are allowed to be manufactured or imported and sold, without or with negligible supporting clinical study or data, and merely based on predicate (device or literature), submitted by the manufacturer or importer. India News | PIL in Delhi HC Against Approval Mechanism for Heart Stents, Notice Issued.
New Delhi, Feb 7: After the Central government told the Supreme Court on Monday that submitting Aadhaar card details is not a mandatory pre-condition on the CO-WIN portal for the COVID-19 vaccination, the top court asked the authorities not to insist on asking people for Aadhaar card for vaccination. While disposing of a PIL claiming some centres insist on a Aadhaar card for vaccination, a Bench of Justices DY Chandrachud and Surya Kant asked the authorities to not insist on […]